Table 4.
Diagnostic categories for the random sample of 240 reports of adverse events after Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine (DTaP) Vaccines in VAERS among persons vaccinated January 1, 1991 through December 31, 2016 (receipt 03/17/2017)
| Diagnostic category | N (%) |
|---|---|
| Nervous system disorders | 60 (25.0) |
| Seizuresa | 48 |
| Gastrointestinal disorders | 56 (23.3) |
| Intussusceptionb | 44 |
| General disorders and administration site conditions Local reactionsc |
47 (19.6) 20 |
| Immune system disorders Anaphylaxisd |
23 (9.6) 11 |
| Infections and Infestations | 19 (7.9) |
| Respiratory, thoracic and mediastinal disorders | 16 (6.7) |
| Blood and lymphatic system disorders | 6 (2.5) |
| Psychiatric disorders | 5 (2.1) |
| Musculoskeletal and connective tissue disorders | 3 (1.3) |
| Othere | 4 (1.7) |
a
Febrile seizures comprised 13 reports
b
Rotavirus vaccine given concurrently in 42 reports
c
Local reactions comprised 45.2% of adverse events in this group
d
One report met Brighton criteria level (BL) 1, one BL 2, one BL 3, and one was not verified as a GBS case
e
Other includes one report each of cardiac disorder, endocrine disorder, eye disorder, and metabolism and nutrition disorder